1. Home
  2. MAIA vs GOCO Comparison

MAIA vs GOCO Comparison

Compare MAIA & GOCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • GOCO
  • Stock Information
  • Founded
  • MAIA 2018
  • GOCO 2001
  • Country
  • MAIA United States
  • GOCO United States
  • Employees
  • MAIA N/A
  • GOCO N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • GOCO Specialty Insurers
  • Sector
  • MAIA Health Care
  • GOCO Finance
  • Exchange
  • MAIA Nasdaq
  • GOCO Nasdaq
  • Market Cap
  • MAIA 56.3M
  • GOCO 64.9M
  • IPO Year
  • MAIA 2022
  • GOCO 2020
  • Fundamental
  • Price
  • MAIA $1.70
  • GOCO $4.81
  • Analyst Decision
  • MAIA
  • GOCO Hold
  • Analyst Count
  • MAIA 0
  • GOCO 1
  • Target Price
  • MAIA N/A
  • GOCO $12.00
  • AVG Volume (30 Days)
  • MAIA 464.6K
  • GOCO 45.5K
  • Earning Date
  • MAIA 11-11-2025
  • GOCO 11-06-2025
  • Dividend Yield
  • MAIA N/A
  • GOCO N/A
  • EPS Growth
  • MAIA N/A
  • GOCO N/A
  • EPS
  • MAIA N/A
  • GOCO N/A
  • Revenue
  • MAIA N/A
  • GOCO $822,444,000.00
  • Revenue This Year
  • MAIA N/A
  • GOCO $2.06
  • Revenue Next Year
  • MAIA N/A
  • GOCO $5.47
  • P/E Ratio
  • MAIA N/A
  • GOCO N/A
  • Revenue Growth
  • MAIA N/A
  • GOCO 17.46
  • 52 Week Low
  • MAIA $1.40
  • GOCO $4.65
  • 52 Week High
  • MAIA $3.48
  • GOCO $21.00
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 58.76
  • GOCO 38.71
  • Support Level
  • MAIA $1.54
  • GOCO $4.65
  • Resistance Level
  • MAIA $1.78
  • GOCO $5.01
  • Average True Range (ATR)
  • MAIA 0.09
  • GOCO 0.25
  • MACD
  • MAIA 0.02
  • GOCO 0.00
  • Stochastic Oscillator
  • MAIA 75.00
  • GOCO 17.93

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

About GOCO GoHealth Inc.

GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.

Share on Social Networks: